Clonotypic immunoglobulin idiotype (Id) (Id)

The clonotypic immunoglobulin idiotype refers to the unique set of antigenic determinants (idiotopes) located within the variable regions of the monoclonal immunoglobulin produced by a malignant plasma cell clone (PubMed: 10545305). In plasma cell dyscrasias like multiple myeloma, this idiotype serves as a definitive tumor-specific antigen because it arises from unique V(D)J recombination events specific to the progenitor B-cell (NIH: NBK538226). Therapeutically, the idiotype is targeted through personalized immunotherapy, most notably idiotype vaccines, which involve conjugating the patient-specific protein to an immunogenic carrier like Keyhole Limpet Hemocyanin (KLH) to break self-tolerance (PubMed: 11500441). These vaccines aim to induce both humoral and cellular immune responses to eliminate the malignant clone while sparing normal B-cells. Despite the high specificity of this approach, challenges include the logistical complexity of custom manufacturing for each patient and the potential for tumor escape through clonal evolution (PubMed: 22403257). Clinically, the idiotype is also the basis for monitoring the M-protein or paraprotein, which serves as a critical biomarker for disease progression and response to therapy (StatPearls: NBK448162).

Other names

Tumor-specific idiotypeMyeloma idiotypeM-protein idiotypeV-region determinantClonotype-specific antigen

Active immunotherapy designed to elicit a patient-specific cytotoxic T-lymphocyte and antibody response against the unique variable regions of the monoclonal immunoglobulin expressed by malignant plasma cells (PubMed: 10545305).